Biotechnology

AgriTalk Integrates Biotechnology, Iot, Big Data Analysis, and Ai to Develop a Non-Toxic Agricultural Disease and Fertilizer Regulation System

TAIPEI, Jan. 3, 2020 /PRNewswire/ -- AgriTalk and other notable homegrown startups led by Taiwan Tech Arena (TTA) are now showcasing their innovative solutions at CES 2020. Dr. W...

2020-01-03 13:14 1268

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- STA Pharmaceutical Co., Ltd.,  (WuXi STA) – a subsidiary of WuXi AppTec – today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility inChangzhou, China. This signifi...

2020-01-03 08:10 2088

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco

SHANGHAI and SUZHOU, China, Dec. 30, 2019 /PRNewswire/ -- Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences inSan Francisco, California at the beginning of January 2020. Gracell will present at the 38th ...

2019-12-30 23:09 1341

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

SEOUL, South Korea, Dec. 26, 2019 /PRNewswire/ -- On Dec. 23, 2019, at Seoul, South Korea, the CDMO segment of the world's leading biotech company GenScript announced that it signed a strategic collaboration agreement with Selecxine Inc., a Korean biotech company dedicated to novel therapeutics f...

2019-12-26 22:00 10980

Viva Biotech Awarded 'Top 10 Public Companies'

BEIJING, Dec. 24, 2019 /PRNewswire/ -- The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held inBeijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor. Dr. David Xu, the Chief Business Officer of Viva Biotech, was ...

2019-12-24 18:18 1478

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation

ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...

2019-12-20 22:00 12918

Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC

SEONGNAM, South Korea, Dec. 19, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company filed an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) and the Ministry...

2019-12-20 10:19 1272

TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure

NANJING, China, Dec. 16, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, a clinical-stage biotechnology company based inNanjing, China, announced today that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for TT-00920, a novel ...

2019-12-17 08:00 1439

Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS

TAIPEI and SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Senhwa Biosciences Inc. (TPEx: 6492), a clinical stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced positive results from its Phase 1 trial of CX-5461. C...

2019-12-13 04:00 2341

Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies

SUZHOU, China and SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd ("Gracell"), a clinical-stage immune cell therapy company, today announced the progressive clinical outcomes for leading product candidates FasTCAR-19, Dual CAR-19-22, and Dual CAR-BCMA-19 at the American...

2019-12-09 22:00 1388

BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors

HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY inSan Antonio, Texas.

2019-12-09 21:00 1512

CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody

SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company committed to discovering and developing a combined platform of Chimeric Antigen Receptor T (CAR-T) cell therapies and monoclonal antibodies for cancer, today announced that one of its leading d...

2019-12-09 18:00 3315

Announcement of collaborative research agreement with National Cancer Center on analysis of gut bacteria related to cancer

TOKYO, Dec. 5, 2019 /PRNewswire/ -- bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President: Hitoshi Nakagama, Chuo-ku, Tokyo, "NCC") have signed a collaborative research agreement on the analysis of gut bacteria related to cancer onNo...

2019-12-05 15:27 832

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

AUSTIN, Texas, Dec. 3, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced results from its latest proof of concept study. A single pre-clinical Nu.Q™ assay utilizing a basic microtiter plate platform detected 80% of newly diagnosed Non-Hodgkins Lymphoma ("N...

2019-12-03 21:30 11790

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain...

2019-12-03 17:36 1106

Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG

Company Expanding its Global Fungicide Portfolio HARPENDEN, England, Dec. 2, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire  rights to the active ingredients Fenamidone and P...

2019-12-03 01:00 1433

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:18 1346

VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution developer and a member company of the Born2Global Centre, will participate in  RSNA (Radiological Society ofNorth America) 2019 in Chicago, December 1-8. Booth: North Hall Level2, #11132.

2019-11-27 21:30 1751

Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park

SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...

2019-11-21 11:30 1697

Two Prominent Researchers of WPI-MANA and University of Washington Discuss Development of Smart Polymers and Biomaterials

TSUKUBA, Japan, Nov. 20, 2019 /PRNewswire/ -- The International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Science (NIMS), had a visit from Prof.Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials...

2019-11-20 14:00 954
1 ... 123124125126127